India's Generic Medicine Exports: A Pillar of Global Healthcare

India is a major exporter of generic medicines, supplying nearly 20% of global demand, thus reducing healthcare costs worldwide. Despite US pressures over intellectual property rights, India maintains its stance of being fully compliant with WTO, prioritizing affordable healthcare through critical provisions.

India's role as a leading exporter of generic medicines has significantly contributed to reducing healthcare costs across the globe, according to the think tank GTRI. Accounting for nearly 20% of global supply, the country's compliance with international intellectual property regulations underscores its pivotal position in the pharmaceuticals industry.

Despite being placed on the Priority Watch List of the United States Trade Representative’s 2026 Special 301 Report, India maintains its commitment to a WTO-compliant intellectual property rights regime, amidst ongoing differences with the US regarding pharmaceutical-related IP protection.

The GTRI highlights that US pressures on India’s pharma IP policies are longstanding, driven by industry lobbying for stricter protections. Nevertheless, India's generics continue to significantly reduce drug prices, affirming its stance as the 'pharmacy of the world' and advocating for affordable healthcare.